PA
Perceptive Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166M | Buy |
+963,886
| New | +$166M | 6.17% | 2 |
|
|
2024
Q1 | – | Sell |
-132,176
| Closed | -$16.6M | – | 108 |
|
|
2023
Q4 | $16.6M | Buy |
+132,176
| New | +$16.6M | 0.37% | 54 |
|
|
2019
Q3 | – | Sell |
-473,475
| Closed | -$54.5M | – | 105 |
|
|
2019
Q2 | $54.5M | Sell |
473,475
-639,853
| -57% | -$73.7M | 1.25% | 19 |
|
|
2019
Q1 | $131M | Buy |
1,113,328
+60,681
| +6% | +$7.14M | 3.7% | 6 |
|
|
2018
Q4 | $63M | Sell |
1,052,647
-20,000
| -2% | -$1.2M | 2.4% | 10 |
|
|
2018
Q3 | $76M | Hold |
1,072,647
| – | – | 2.03% | 10 |
|
|
2018
Q2 | $71.4M | Buy |
1,072,647
+90,000
| +9% | +$5.99M | 1.87% | 12 |
|
|
2018
Q1 | $64.3M | Buy |
+982,647
| New | +$64.3M | 1.8% | 15 |
|
|
2015
Q3 | – | Sell |
-10,000
| Closed | -$176K | – | 143 |
|
|
2015
Q2 | $176K | Hold |
10,000
| – | – | 0.01% | 155 |
|
|
2015
Q1 | $174K | Buy |
+10,000
| New | +$174K | 0.01% | 141 |
|